Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India [clinicaltrials:NCT01462422]

Bio2RDF uri

Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India [clinicaltrials:NCT01462422]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT01462422

Bio2RDF identifier

NCT01462422

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01462422

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT01462422

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

3,032

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT01462422 arm group 69ab4b831f649bebc1c2ef200e27a32c [clinicaltrials_resource:NCT01462422/arm-group/69ab4b831f649bebc1c2ef200e27a32c]

NCT01462422 arm group 84b94a004786fbe9a125981772d7d857 [clinicaltrials_resource:NCT01462422/arm-group/84b94a004786fbe9a125981772d7d857]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:ad85bc6e16ea4839908ad5c88c8b79d1

brief summary [clinicaltrials_vocabulary:brief-summary]

This study compares two ...... care using misoprostol.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Misoprostol for Secondary Prev ...... t the Community Level in India

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:d911c72aca4b984ede779525195a7d38]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:12af660519d0d187c855203027e9cb4f]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:2e78dcee891a3990eb242c072ebad1fd]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:3181da437430329e1a47f8f8725b8f17]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:5d04c123338e67f4593148c0a238c3a0]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:95c02a18d393ce552176ed6c34e9acbf]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:ac747827ef34af2a0aa09da9e90a12f3]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:bf0952ff2a3211f2b22847e07ed88b17]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:c1576096f4d4268d4f7e024f9d43ac70]

Proportion of women with post-delivery hemoglobin ≤ 7.8 gm/dL 72 hours (plus or minus 8 hours) after delivery [clinicaltrials_resource:e1060d3cba919ea99cbf711fd03997de]

collaborator [clinicaltrials_vocabulary:collaborator]

Gynuity Health Projects [clinicaltrials_resource:1f093b56ada9442df08e4e48d8e39777]

completion date [clinicaltrials_vocabulary:completion-date]

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

Rationale for Research: ...... condary prevention arm.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01462422 [clinicaltrials_resource:138053483fe2762eec709b45e8bc86b8]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2011-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Misoprostol [clinicaltrials_resource:219739008a44fe7ebcba0cc8b9c25bb7]

Misoprostol [clinicaltrials_resource:e80f56985fa466d4e242c550f1f51f22]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Misoprostol [clinicaltrials_resource:f66a8d5d8b426c2e247213e1e748dff2]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Developing countries

http://www.w3.org/2001/XMLSchema#string

Misoprostol

http://www.w3.org/2001/XMLSchema#string

Nurse midwife

http://www.w3.org/2001/XMLSchema#string

Postpartum hemorrhage

http://www.w3.org/2001/XMLSchema#string

Prevention

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2014-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Gynuity Health Projects [clinicaltrials_resource:1f093b56ada9442df08e4e48d8e39777]

link [clinicaltrials_vocabulary:link]

Gynuity Health Projects [clinicaltrials_resource:2012ec0c3ccca6db845b4c331c0994b9]

location [clinicaltrials_vocabulary:location]

Deliveries at health sub-centers and homes [clinicaltrials_resource:2d3571778e8771dd8a04134676877250]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01462422

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Two Community Strategies Compa ...... pur District, Karnataka, India

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

2.4.16

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Beverly Winikoff, MD, MPH [clinicaltrials_resource:2475305bc5ad2844b93175264897f915]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

India: Indian Council of Medical Research [clinicaltrials_resource:cc3597bac7301f013a5d8a33f0d24db6]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

Gynuity Health Projects [clinicaltrials_resource:1f093b56ada9442df08e4e48d8e39777]

start date [clinicaltrials_vocabulary:start-date]

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01462422 study design [clinicaltrials_resource:19496687ec46798e09c67654502634df]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT01462422

verification date [clinicaltrials_vocabulary:verification-date]

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01462422

http://www.w3.org/2001/XMLSchema#string

title

Misoprostol for Secondary Prev ...... t the Community Level in India

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Misoprostol for Secondary Prev ...... a [clinicaltrials:NCT01462422]

@en